NCT04228445View on ClinicalTrials.gov

3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency

PHASE3CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

June 3, 2021

Study Completion Date

June 3, 2021

Conditions

Ureter Injury

Interventions

DRUG

3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%

Experimental contrast dye that is commonly used as a visualization aid in pelvic and abdominal surgeries and for various diagnostic procedures in medical practice.

DRUG

Saline spray

Placebo

Trial Locations (1)

68114

Adult and Pediatric Urology, Omaha

All Listed Sponsors

lead

Prove pharm

INDUSTRY

NCT04228445 - 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency | Biotech Hunter | Biotech Hunter